C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/82 (2006.01) C12N 5/0783 (2010.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/47 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2440303
A cancer antigen peptide containing the following amino acid sequence Cys-Tyr- Thr-Trp-Asn-Gln-Met-Asn-Leu (SEQ ID NO:3); a vaccine for cancer containing the same as the active ingredient; and a DNA vaccine containing a DNA encoding this peptide as the active ingredient.
L'invention concerne un peptide antigène de cancer renfermant la séquence d'acides aminés suivante Cys-Tyr-Thr-Trp-Asn-Gln-Met-Asn-Leu (SEQ ID : 3) ; un vaccin contre le cancer renfermant ce peptide comme principe actif ; ainsi qu'un vaccin d'ADN renfermant un ADN codant ce peptide comme principe actif.
Borden Ladner Gervais Llp
International Institute Of Cancer Immunology Inc.
Sugiyama Haruo
LandOfFree
Wti modified peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wti modified peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wti modified peptide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2057163